1. Introduction {#sec1}
===============

Colitis can originate from a wide range of etiologies including ischemic, infectious, and inflammatory bowel disease. A thorough history is imperative to determine the causative nature of the patient\'s presenting symptoms. Investigations range from observation and stool analysis, to endoscopy with biopsies, depending upon particular risk factors and severity of symptoms. A growing subset of colitis is antibiotic associated colitis. A majority of these cases are secondary to*Clostridium difficile* infection (CDI), with an estimated 453,000 cases of CDI throughout the United States in 2011 \[[@B1]\]. Within the most common antibiotics used, antibiotic associated diarrhea has been reported in 5-10% of patients taking ampicillin, 10 to 25% of those who are treated with amoxicillin--clavulanate, 15 to 20% of those who receive cefixime, and 2 to 5% of those who are treated with other cephalosporins, fluoroquinolones, azithromycin, clarithromycin, erythromycin, and tetracycline \[[@B2]\]. Yet, in cases of clostridium difficile-negative antibiotic associated hemorrhagic colitis (AAHC),*Klebsiella oxytoca* has been isolated at a significantly high rate \[[@B3]\]. In Hogenauer et al.\'s study, 385 healthy patients had stool testing for*Klebsiella oxytoca* and in 1.6% of the patients, the pathogen was isolated \[[@B4]\]. Interestingly,*Klebsiella oxytoca* is found mainly in young healthy individuals compared to patients with CDI who are generally older and with previous hospitalizations \[[@B4]\]. Here we present a case of*Clostridium difficile*-negative AAHC caused by*K. oxytoca* infection after taking ampicillin for a urinary tract infection.

2. Case Presentation {#sec2}
====================

A 33-year-old Caucasian female with significant family history of inflammatory bowel disease (IBD) presents with profuse, bloody diarrhea for 5 days and associated tenesmus and urgency. One day prior to admission, she completed a one-week course of ampicillin for a urinary tract infection and noted that her symptoms began three days after she had initiated treatment. On presentation, patient was hemodynamically stable, afebrile, with mild lower abdominal pain, and a positive guaiac exam. Laboratory findings showed WBC 12.4 bil/L (normal values 3.3--10.7 bil/L), neutrophils 11.0 bil/L (normal values 1.6--7.2 bil/L), Hgb 13.1 g/dL (normal values 12.1--15.0 g/dL), platelets 275 bil/L (normal values 150--400 bil/L), lactic acid 1.4 mmol/L (normal values 0.5--2.2 mmol/L), and liver function tests within normal limits. Initial stool studies that included stool culture, ova and parasite, and*Clostridium difficile* toxin PCR were negative. A colonoscopy was planned as the patient had an extensive family history of IBD and presented with bloody diarrhea.*Klebsiella oxytoca* testing was requested on the stool culture after*Clostridium difficile* PCR came back negative, given her previous use of penicillins. Colonoscopy was notable for ulcerated mucosa with erythema and easy friability, suggestive of moderate colitis throughout the colon with rectosigmoid sparing ([Figure 1](#fig1){ref-type="fig"}). Colonic biopsy was remarkable for mucosal congestion and ischemia suggestive of ischemic colitis ([Figure 2](#fig2){ref-type="fig"}). Subsequently, requested stool culture was positive for many*Klebsiella oxytoca*. The patient\'s hematochezia resolved prior to discharge on day 3 of hospitalization, four days after cessation of ampicillin. She was advised to avoid future use of penicillins and minimize nonsteroidal anti-inflammatory drug (NSAID) use.

The patient has continued to follow with her gastroenterologist 10 months after her colonoscopy. She has had epigastric abdominal pain relieved by daily omeprazole. She no longer has documented hematochezia and there has been no repeat colonoscopy.

3. Discussion {#sec3}
=============

Colitis is a well-known complication of treatment with antibiotic agents, yet the cause of antibiotic associated hemorrhagic colitis is not completely understood. Several mechanisms have been proposed including allergic reaction, mucosal ischemia, and*Klebsiella oxytoca* infection.*Klebsiella oxytoca* positive hemorrhagic colitis is a rare form of antibiotic associated hemorrhagic colitis that is*Clostridium difficile* negative \[[@B4]\]. In 1978, Toffler et al. were the first to describe AAHC \[[@B5]\]. It has been described that, in a majority of cases, penicillin and penicillin derivative administration typically precede AAHC; however, quinolones and cephalosporins have been described as well \[[@B6]\].

There appears to be a greater incidence of AAHC secondary to*K. oxytoca* in the Japanese population \[[@B7]\].*K. oxytoca* has been reported in the United States as well, yet appears to be more rare. A PubMed literature review was conducted in order to consolidate all English written and adult population case reports on*K. oxytoca* hemorrhagic colitis. Search was conducted via the phrases "Klebsiella oxytoca AND colitis AND case report" and "colitis AND Klebsiella oxytoca." A total of 74 articles resulted, 18 of which were case reports: 7 written in English, 8 written in French, and 3 written in Japanese. The English written cases range from the years 1999 to 2017 and total 9 cases. Five of the cases are reported from Japan and 4 from cities throughout the United States. Ages range from 37 years to 85 years with 4 males and 5 females. Eight of the 9 cases reported bloody diarrhea. The types of antibiotics reported were three penicillin derivatives (amoxicillin twice and amoxicillin-clavulanic acid once), one macrolide (clarithromycin), three fluoroquinolones (tosufloxacin, enoxacin, and levofloxacin), and one with metronidazole, and one case only reported perioperative antibiotics yet specifics were unknown. Two of the 9 cases noted prior use of a NSAID. Duration of antibiotic use ranged from 1 to 7 days. Interestingly, there was a delay of 3-4 weeks in symptomatology in patients who had taken fluoroquinolones compared to the other patients in which symptoms began closer to time of antibiotic use. Location of endoscopic findings varied throughout the 9 cases. Of the 9 cases, 2 cases were right sided only, 3 cases were from ascending to descending colon, 2 cases only involved the sigmoid colon, 1 case involved the transverse colon, and 1 patient declined colonoscopy. The duration of time for resolution of symptoms ranged from 4 days to 3 weeks. Seven of the 9 cases were treated supportively (one case was treated with prednisolone as well). Two of the 9 cases were treated with fluoroquinolones (one of the cases with metronidazole as well) with no reported recurrence of symptoms. In all cases, antibiotic course was either completed or terminated early prior to symptomatic improvement ([Table 1](#tab1){ref-type="table"}). The diagnosis of*K. oxytoca* can be established by stool \[[@B6], [@B9]--[@B14], [@B16]\], tissue \[[@B8]\], or bacterial \[[@B15]\] culture. The priority of which culture is of highest yield is uncertain. Of the 9 cases, the most common past medical history was type 2 diabetes mellitus in 3 of the patients, hypertension in 2 of the patients, and systemic lupus erythematosus in 1 of the patients.

Our case is rare given her Caucasian ethnicity; however, as evident by [Table 1](#tab1){ref-type="table"},*K. oxytoca* in Caucasians have been reported in the past. The patient\'s symptomatology, duration of symptoms, and time for resolution of symptoms are consistent with previous reported cases \[[@B9], [@B10], [@B11]\]. There have been reports of symptoms manifesting weeks after antibiotic course, yet these were reported after fluoroquinolone use \[[@B6]\]. Her age and lack of risk factors for hemorrhagic colitis are also consistent with previous described cases \[[@B4]\]. Colonic biopsy is generally misinterpreted as ischemic colitis \[[@B6]--[@B10]\], just as in this case. Diagnosis is made upon stool culture of*K. oxytoca*, which has to be specifically requested. Stool culture of*K. oxytoca* can result within 24 hours of testing. If suspicion is high enough, and physician is aware of such entity, diagnosis of AAHC secondary to*K. oxytoca* can be made and can possibly prevent unnecessary and risky diagnostic procedures. The disease course is generally self-limited with withdrawal of the offending penicillin. Avoidance of NSAIDs is recommended as well, as this can exacerbate the colitis in these patients \[[@B8], [@B11], [@B12]\]. It is unclear at this time if readministration of ampicillin would lead to a similar episode \[[@B13]\]; however, the patient has been advised to avoid all penicillins.

In conclusion, we presented a case of*K. oxytoca* colitis in order to raise awareness of the possible etiology of AAHC to be considered in young patients taking antibiotics in which the simple interruption of antibiotic should improve the symptomatology and potentially avoid unnecessary testing or invasive procedures like colonoscopy to be done.
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![Endoscopic view of ulcerated mucosa with erythema and easy friability, suggestive of moderate colitis.](CRIGM2018-7264613.001){#fig1}

![Colonic biopsy. Yellow arrow indicates epithelial surface erosion. Green arrow indicates extravasated red blood cells. Orange arrow indicates lymphocytes. Blue star indicates reactive intestinal glands.](CRIGM2018-7264613.002){#fig2}

###### 

Literature review of case reports of colitis secondary to *Klebsiella oxytoca*.

  **Author**                               **Year and Location**   **Patient Age and Gender**   **Presenting symptoms**                    **Antibiotic prior to presentation**             **NSAID use prior to presen- tation**   **Duration of Abx prior to sx**   **Endo- scopic location of disease**   **Time to reso- lution of sx**   **Treatment**
  ---------------------------------------- ----------------------- ---------------------------- ------------------------------------------ ------------------------------------------------ --------------------------------------- --------------------------------- -------------------------------------- -------------------------------- ------------------------------------
  Koga et al. \[[@B6]\]                    1999 Japan              37 y/o Female                Bloody diarrhea and abdominal pain         Tosu- floxacin tosylate 450 mg                   none                                    5 days∗                           Entire colon excluding rectum          2 weeks                          Hydration and Loperamide
                                                                                                                                                                                                                                                                                                                                              
  Koga et al. \[[@B6]\]                    1999 Japan              46 y/o Male                  Bloody diarrhea and abdominal pain         Enoxacin                                         none                                    7 days∗                           Right sided                            3 weeks                          Supportive
                                                                                                                                                                                                                                                                                                                                              
  Koga et al. \[[@B6]\]                    1999 Japan              37 y/o Male                  Bloody diarrhea                            Levo- floxacin 300 mg                            none                                    7 days∗                           Transverse to sigmoid                  3 weeks                          Supportive
                                                                                                                                                                                                                                                                                                                                              
  Chen, Cachay, and Hunt \[[@B8]\]         2004 San Diego, CA      79 y/o Male                  Diarrhea, abdominal pain, hemato- chezia   none                                             Aspirin                                 none                              Sigmoid colon                          2 weeks                          Cipro- floxacin
                                                                                                                                                                                                                                                                                                                                              
  Philbrick, Ernst \[[@B9]\]               2007 Iowa               63 y/o Male                  Watery diarrhea and BRBPR                  Amoxicillin 500 mg q8h                           Ibuprofen 800mg q8h                     5 days                            Ascending to descending colon          1 week                           Metro- nidazole and Levo- floxacin
                                                                                                                                                                                                                                                                                                                                              
  Miyauchi, Kinoshita, Tokuda \[[@B10]\]   2013 Japan              67 y/o Female                Mucobloody diarrhea and abdominal pain     Clarithro- mycin 200 mg q12h                     none                                    5 days                            Right sided                            Not specified                    Supportive
                                                                                                                                                                                                                                                                                                                                              
  Sweetser, Schroede, Pardi \[[@B14]\]     2009 Rochester, MN      67 y/o Female                Watery diarrhea                            Peri- operative abx                              none                                    3 days                            Sigmoid colon                          4 days                           Supportive
                                                                                                                                                                                                                                                                                                                                              
  Kazuyuki et al. \[[@B15]\]               2017 Japan              65 y/o Female                Abdominal pain and hemato- chezia          Amoxicillin 1500 mg and Metro- nidazole 500 mg   none                                    1 day                             Transverse colon                       6 days                           Bowel rest and prednisolone
                                                                                                                                                                                                                                                                                                                                              
  Akanbi et al.\[[@B16]\]                  2017 Chicago, IL        85 y/o Female                Abdominal pain and muco- bloody diarrhea   Amoxicillin - clavulanic acid                    none                                    5 days                            Declined colon- oscopy                 5 days                           Supportive care

^∗^Symptoms did not start until \~3-4 weeks after antibiotic cessation.

Q8h, every 8 hours; q12h, every 12 hours; BRBPR, bright red blood per rectum; abx, antibiotics; ASA, aspirin; sx, symptoms; y/o, years old.
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